You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR ALTOPREV

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ALTOPREV

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00285857 ↗	Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention	Terminated	Stanford University	Phase 2	2005-11-01	The study evaluates if a 6-month course of oral lovastatin at 80 mg/day would decrease abnormal breast duct cytology in women with a high inherited breast cancer risk.
NCT00302952 ↗	Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis	Terminated	Autoimmunity Centers of Excellence	Phase 2	2007-11-06	Rheumatoid arthritis (RA) is the most common inflammatory arthritis and a major health problem. The purpose of this study is to determine the safety and effectiveness of lovastatin for controlling inflammation in mildly active RA.
NCT00302952 ↗	Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis	Terminated	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	2007-11-06	Rheumatoid arthritis (RA) is the most common inflammatory arthritis and a major health problem. The purpose of this study is to determine the safety and effectiveness of lovastatin for controlling inflammation in mildly active RA.
NCT00580970 ↗	Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury	Completed	Hunter Holmes Mcguire Veteran Affairs Medical Center	Phase 2	2007-04-01	Lovastatin may protect against late effects of radiation therapy in patients with prostate cancer
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ALTOPREV

Condition Name

Chart
Table

Condition Name for ALTOPREV
Intervention	Trials
Breast Cancer	1
Hyperlipidemias	1
Ovarian Cancer	1
Prostate Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ALTOPREV
Intervention	Trials
Arthritis	1
Carcinoma, Ovarian Epithelial	1
Breast Neoplasms	1
Leukemia, Myeloid, Acute	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ALTOPREV

Trials by Country

Map
Table

Trials by Country for ALTOPREV
Location	Trials
United States	17
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ALTOPREV
Location	Trials
Iowa	2
California	2
Virginia	1
Utah	1
Texas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ALTOPREV

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ALTOPREV
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	4
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ALTOPREV
Clinical Trial Phase	Trials
Terminated	4
Completed	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALTOPREV

Sponsor Name

Chart
Table

Sponsor Name for ALTOPREV
Sponsor	Trials
University of Iowa	2
Stanford University	1
Autoimmunity Centers of Excellence	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ALTOPREV
Sponsor	Trials
Other	6
NIH	1
U.S. Fed	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.